Effect of Platelet Storage on Complement Activation
NCT03280823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2017-09-13
Summary
Platelet units are stored and complement factors are evaluated
Conditions
- Platelet Storage
Sponsors & Collaborators
-
Shimaa Abdeleem
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2018-09-30
- Completion
- 2018-12-31
More Related Trials
-
A Clinical Trial of Chidamide in the Management of Refractory ITP
NCT03838354 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
NCT00261924 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
NCT05832216 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Function With Various Storage Techniques
NCT03338660 ·Status: WITHDRAWN ·Phase: PHASE2
-
Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets
NCT05111028 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Study of Different Dose Rituximab in the Treatment of ITP
NCT03258866 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP
NCT04368598 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients
NCT05944458 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure
NCT04915287 ·Status: UNKNOWN ·Phase: PHASE4
-
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 ·Status: RECRUITING
-
Platelet and Immune Response in Covid-19 Vaccine
NCT05171959 ·Status: UNKNOWN
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
NCT02868060 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim
NCT04638829 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302 ·Status: COMPLETED
-
Eltrombopag in Chronic ITP
NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
NCT01703169 ·Status: COMPLETED ·Phase: PHASE2
-
Role of ROTEM and Platelet Indices in Thrombocytopenic Patients .
NCT05850481 ·Status: UNKNOWN
-
The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
NCT01869049 ·Status: WITHDRAWN
-
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
NCT01566695 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
NCT00903929 ·Status: COMPLETED ·Phase: PHASE1
-
Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
NCT05628974 ·Status: RECRUITING
-
Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
NCT02689986 ·Status: COMPLETED ·Phase: PHASE2